Lucia Vráblová, Hana Klamova, I. Skoumalová, Jana Navrátilová, R. Janská, Janine Grohmann, Milena Holzerová, Edgar Faber
{"title":"对长期治疗失败的慢性骨髓性白血病(CML)患者因明显的血液学毒性而使用小剂量酪氨酸激酶抑制剂治疗,可防止血液学进展","authors":"Lucia Vráblová, Hana Klamova, I. Skoumalová, Jana Navrátilová, R. Janská, Janine Grohmann, Milena Holzerová, Edgar Faber","doi":"10.1016/j.htct.2024.03.010","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":94026,"journal":{"name":"Hematology, transfusion and cell therapy","volume":"2019 27","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treatment with low-dose tyrosine kinase inhibitors due to significant haematologic toxicity in patients with CML with prolonged treatment failure prevents haematologic progression\",\"authors\":\"Lucia Vráblová, Hana Klamova, I. Skoumalová, Jana Navrátilová, R. Janská, Janine Grohmann, Milena Holzerová, Edgar Faber\",\"doi\":\"10.1016/j.htct.2024.03.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":94026,\"journal\":{\"name\":\"Hematology, transfusion and cell therapy\",\"volume\":\"2019 27\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematology, transfusion and cell therapy\",\"FirstCategoryId\":\"0\",\"ListUrlMain\":\"https://doi.org/10.1016/j.htct.2024.03.010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology, transfusion and cell therapy","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.1016/j.htct.2024.03.010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Treatment with low-dose tyrosine kinase inhibitors due to significant haematologic toxicity in patients with CML with prolonged treatment failure prevents haematologic progression